Since the oncogenic mutations of PIK3CA are found to trigger luminal ER+PR+ tumors in a transgenic mouse model [31], constitutively activated PI3K/AKT pathway may cooperate with ERα to promote invasiveness of ER+ breast cancer. This evidence concerns the gene ESR1 and breast cancer.